Global Non-Animal Softgel Capsules Market Growth 2021-2026
According to this latest study, the 2021 growth of Non-Animal Softgel Capsules will have significant change from previous year. By the most conservative estimates of global Non-Animal Softgel Capsules market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 505.8 million in 2020. Over the next five years the Non-Animal Softgel Capsules market will register a 7.5% CAGR in terms of revenue, the global market size will reach US$ 674.6 million by 2026._x000D_
_x000D_
This report presents a comprehensive overview, market shares, and growth opportunities of Non-Animal Softgel Capsules market by product type, application, key manufacturers and key regions and countries._x000D_
_x000D_
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7._x000D_
Plant Polysaccharides Softgel Capsules_x000D_
Starch Softgel Capsules_x000D_
_x000D_
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8._x000D_
Health Supplements_x000D_
Pharmaceutical_x000D_
Others_x000D_
_x000D_
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8._x000D_
Americas_x000D_
United States_x000D_
Canada_x000D_
Mexico_x000D_
Brazil_x000D_
APAC_x000D_
China_x000D_
Japan_x000D_
Korea_x000D_
Southeast Asia_x000D_
India_x000D_
Australia_x000D_
Europe_x000D_
Germany_x000D_
France_x000D_
UK_x000D_
Italy_x000D_
Russia_x000D_
Middle East & Africa_x000D_
Egypt_x000D_
South Africa_x000D_
Israel_x000D_
Turkey_x000D_
GCC Countries_x000D_
_x000D_
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3._x000D_
Catalent_x000D_
Procaps Laboratorios_x000D_
EuroCaps_x000D_
Best Formulations_x000D_
Aenova_x000D_
Captek_x000D_
Sirio_x000D_
Bahrain Pharma_x000D_
Robinson Pharma_x000D_
Aland_x000D_
Fuji Capsule_x000D_
Sunsho Pharmaceutical_x000D_
Erkang_x000D_
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report_x000D_
1.1 Market Introduction_x000D_
1.2 Years Considered_x000D_
1.3 Research Objectives_x000D_
1.4 Market Research Methodology_x000D_
1.5 Research Process and Data Source_x000D_
1.6 Economic Indicators_x000D_
1.7 Currency Considered_x000D_
_x000D_
2 Executive Summary_x000D_
2.1 World Market Overview_x000D_
2.1.1 Global Non-Animal Softgel Capsules Consumption 2016-2026_x000D_
2.1.2 Non-Animal Softgel Capsules Consumption CAGR by Region_x000D_
2.2 Non-Animal Softgel Capsules Segment by Type_x000D_
2.2.1 Plant Polysaccharides Softgel Capsules_x000D_
2.2.2 Starch Softgel Capsules_x000D_
2.3 Non-Animal Softgel Capsules Sales by Type_x000D_
2.3.1 Global Non-Animal Softgel Capsules Sales Market Share by Type (2016-2021)_x000D_
2.3.2 Global Non-Animal Softgel Capsules Revenue and Market Share by Type (2016-2021)_x000D_
2.3.3 Global Non-Animal Softgel Capsules Sale Price by Type (2016-2021)_x000D_
2.4 Non-Animal Softgel Capsules Segment by Application_x000D_
2.4.1 Health Supplements_x000D_
2.4.2 Pharmaceutical_x000D_
2.4.3 Others_x000D_
2.5 Non-Animal Softgel Capsules Sales by Application_x000D_
2.5.1 Global Non-Animal Softgel Capsules Sale Market Share by Application (2016-2021)_x000D_
2.5.2 Global Non-Animal Softgel Capsules Revenue and Market Share by Application (2016-2021)_x000D_
2.5.3 Global Non-Animal Softgel Capsules Sale Price by Application (2016-2021)_x000D_
_x000D_
3 Global Non-Animal Softgel Capsules by Company_x000D_
3.1 Global Non-Animal Softgel Capsules Sales Market Share by Company_x000D_
3.1.1 Global Non-Animal Softgel Capsules Sales by Company (2019-2021)_x000D_
3.1.2 Global Non-Animal Softgel Capsules Sales Market Share by Company (2019-2021)_x000D_
3.2 Global Non-Animal Softgel Capsules Revenue Market Share by Company_x000D_
3.2.1 Global Non-Animal Softgel Capsules Revenue by Company (2019-2021)_x000D_
3.2.2 Global Non-Animal Softgel Capsules Revenue Market Share by Company (2019-2021)_x000D_
3.3 Global Non-Animal Softgel Capsules Sale Price by Company_x000D_
3.4 Global Manufacturers Non-Animal Softgel Capsules Producing Area Distribution, Sales Area, Product Type_x000D_
3.4.1 Key Manufacturers Non-Animal Softgel Capsules Product Location Distribution_x000D_
3.4.2 Players Non-Animal Softgel Capsules Products Offered_x000D_
3.5 Market Concentration Rate Analysis_x000D_
3.5.1 Competition Landscape Analysis_x000D_
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)_x000D_
3.6 New Products and Potential Entrants_x000D_
3.7 Mergers & Acquisitions, Expansion_x000D_
_x000D_
4 Non-Animal Softgel Capsules by Region_x000D_
4.1 Global Non-Animal Softgel Capsules by Region_x000D_
4.1.1 Global Non-Animal Softgel Capsules Sales by Region_x000D_
4.1.2 Global Non-Animal Softgel Capsules Revenue by Region_x000D_
4.2 Americas Non-Animal Softgel Capsules Sales Growth_x000D_
4.3 APAC Non-Animal Softgel Capsules Sales Growth_x000D_
4.4 Europe Non-Animal Softgel Capsules Sales Growth_x000D_
4.5 Middle East & Africa Non-Animal Softgel Capsules Sales Growth_x000D_
_x000D_
5 Americas_x000D_
5.1 Americas Non-Animal Softgel Capsules Sales by Country_x000D_
5.1.1 Americas Non-Animal Softgel Capsules Sales by Country (2016-2021)_x000D_
5.1.2 Americas Non-Animal Softgel Capsules Revenue by Country (2016-2021)_x000D_
5.2 Americas Non-Animal Softgel Capsules Sales by Type_x000D_
5.3 Americas Non-Animal Softgel Capsules Sales by Application_x000D_
5.4 United States_x000D_
5.5 Canada_x000D_
5.6 Mexico_x000D_
5.7 Brazil_x000D_
_x000D_
6 APAC_x000D_
6.1 APAC Non-Animal Softgel Capsules Sales by Region_x000D_
6.1.1 APAC Non-Animal Softgel Capsules Sales by Region (2016-2021)_x000D_
6.1.2 APAC Non-Animal Softgel Capsules Revenue by Region (2016-2021)_x000D_
6.2 APAC Non-Animal Softgel Capsules Sales by Type_x000D_
6.3 APAC Non-Animal Softgel Capsules Sales by Application_x000D_
6.4 China_x000D_
6.5 Japan_x000D_
6.6 Korea_x000D_
6.7 Southeast Asia_x000D_
6.8 India_x000D_
6.9 Australia_x000D_
_x000D_
7 Europe_x000D_
7.1 Europe Non-Animal Softgel Capsules by Country_x000D_
7.1.1 Europe Non-Animal Softgel Capsules Sales by Country (2016-2021)_x000D_
7.1.2 Europe Non-Animal Softgel Capsules Revenue by Country (2016-2021)_x000D_
7.2 Europe Non-Animal Softgel Capsules Sales by Type_x000D_
7.3 Europe Non-Animal Softgel Capsules Sales by Application_x000D_
7.4 Germany_x000D_
7.5 France_x000D_
7.6 UK_x000D_
7.7 Italy_x000D_
7.8 Russia_x000D_
_x000D_
8 Middle East & Africa_x000D_
8.1 Middle East & Africa Non-Animal Softgel Capsules by Country_x000D_
8.1.1 Middle East & Africa Non-Animal Softgel Capsules Sales by Country (2016-2021)_x000D_
8.1.2 Middle East & Africa Non-Animal Softgel Capsules Revenue by Country (2016-2021)_x000D_
8.2 Middle East & Africa Non-Animal Softgel Capsules Sales by Type_x000D_
8.3 Middle East & Africa Non-Animal Softgel Capsules Sales by Application_x000D_
8.4 Egypt_x000D_
8.5 South Africa_x000D_
8.6 Israel_x000D_
8.7 Turkey_x000D_
8.8 GCC Country_x000D_
_x000D_
9 Market Drivers, Challenges and Trends_x000D_
9.1 Market Drivers and Impact_x000D_
9.1.1 Growing Demand from Key Regions_x000D_
9.1.2 Growing Demand from Key Applications and Potential Industries_x000D_
9.2 Market Challenges and Impact_x000D_
9.3 Market Trends_x000D_
_x000D_
10 Marketing, Distributors and Customer_x000D_
10.1 Sales Channel_x000D_
10.1.1 Direct Channels_x000D_
10.1.2 Indirect Channels_x000D_
10.2 Non-Animal Softgel Capsules Distributors_x000D_
10.3 Non-Animal Softgel Capsules Customer_x000D_
_x000D_
11 Global Non-Animal Softgel Capsules Market Forecast_x000D_
11.1 Global Non-Animal Softgel Capsules Forecast by Region_x000D_
11.1.1 Global Non-Animal Softgel Capsules Forecast by Regions (2021-2026)_x000D_
11.2.2 Global Non-Animal Softgel Capsules Revenue Forecast by Regions (2021-2026)_x000D_
11.2 Americas Forecast by Country_x000D_
11.3 APAC Forecast by Region_x000D_
11.4 Europe Forecast by Country_x000D_
11.5 Middle East & Africa Forecast by Country_x000D_
11.6 Global Non-Animal Softgel Capsules Forecast by Type_x000D_
11.7 Global Non-Animal Softgel Capsules Forecast by Application_x000D_
_x000D_
12 Key Players Analysis_x000D_
12.1 Catalent_x000D_
12.1.1 Catalent Company Information_x000D_
12.1.2 Catalent Non-Animal Softgel Capsules Product Offered_x000D_
12.1.3 Catalent Non-Animal Softgel Capsules Sales, Revenue, Price and Gross Margin (2019-2021)_x000D_
12.1.4 Catalent Main Business Overview_x000D_
12.1.5 Catalent Latest Developments_x000D_
12.2 Procaps Laboratorios_x000D_
12.2.1 Procaps Laboratorios Company Information_x000D_
12.2.2 Procaps Laboratorios Non-Animal Softgel Capsules Product Offered_x000D_
12.2.3 Procaps Laboratorios Non-Animal Softgel Capsules Sales, Revenue, Price and Gross Margin (2019-2021)_x000D_
12.2.4 Procaps Laboratorios Main Business Overview_x000D_
12.2.5 Procaps Laboratorios Latest Developments_x000D_
12.3 EuroCaps_x000D_
12.3.1 EuroCaps Company Information_x000D_
12.3.2 EuroCaps Non-Animal Softgel Capsules Product Offered_x000D_
12.3.3 EuroCaps Non-Animal Softgel Capsules Sales, Revenue, Price and Gross Margin (2019-2021)_x000D_
12.3.4 EuroCaps Main Business Overview_x000D_
12.3.5 EuroCaps Latest Developments_x000D_
12.4 Best Formulations_x000D_
12.4.1 Best Formulations Company Information_x000D_
12.4.2 Best Formulations Non-Animal Softgel Capsules Product Offered_x000D_
12.4.3 Best Formulations Non-Animal Softgel Capsules Sales, Revenue, Price and Gross Margin (2019-2021)_x000D_
12.4.4 Best Formulations Main Business Overview_x000D_
12.4.5 Best Formulations Latest Developments_x000D_
12.5 Aenova_x000D_
12.5.1 Aenova Company Information_x000D_
12.5.2 Aenova Non-Animal Softgel Capsules Product Offered_x000D_
12.5.3 Aenova Non-Animal Softgel Capsules Sales, Revenue, Price and Gross Margin (2019-2021)_x000D_
12.5.4 Aenova Main Business Overview_x000D_
12.5.5 Aenova Latest Developments_x000D_
12.6 Captek_x000D_
12.6.1 Captek Company Information_x000D_
12.6.2 Captek Non-Animal Softgel Capsules Product Offered_x000D_
12.6.3 Captek Non-Animal Softgel Capsules Sales, Revenue, Price and Gross Margin (2019-2021)_x000D_
12.6.4 Captek Main Business Overview_x000D_
12.6.5 Captek Latest Developments_x000D_
12.7 Sirio_x000D_
12.7.1 Sirio Company Information_x000D_
12.7.2 Sirio Non-Animal Softgel Capsules Product Offered_x000D_
12.7.3 Sirio Non-Animal Softgel Capsules Sales, Revenue, Price and Gross Margin (2019-2021)_x000D_
12.7.4 Sirio Main Business Overview_x000D_
12.7.5 Sirio Latest Developments_x000D_
12.8 Bahrain Pharma_x000D_
12.8.1 Bahrain Pharma Company Information_x000D_
12.8.2 Bahrain Pharma Non-Animal Softgel Capsules Product Offered_x000D_
12.8.3 Bahrain Pharma Non-Animal Softgel Capsules Sales, Revenue, Price and Gross Margin (2019-2021)_x000D_
12.8.4 Bahrain Pharma Main Business Overview_x000D_
12.8.5 Bahrain Pharma Latest Developments_x000D_
12.9 Robinson Pharma_x000D_
12.9.1 Robinson Pharma Company Information_x000D_
12.9.2 Robinson Pharma Non-Animal Softgel Capsules Product Offered_x000D_
12.9.3 Robinson Pharma Non-Animal Softgel Capsules Sales, Revenue, Price and Gross Margin (2019-2021)_x000D_
12.9.4 Robinson Pharma Main Business Overview_x000D_
12.9.5 Robinson Pharma Latest Developments_x000D_
12.10 Aland_x000D_
12.10.1 Aland Company Information_x000D_
12.10.2 Aland Non-Animal Softgel Capsules Product Offered_x000D_
12.10.3 Aland Non-Animal Softgel Capsules Sales, Revenue, Price and Gross Margin (2019-2021)_x000D_
12.10.4 Aland Main Business Overview_x000D_
12.10.5 Aland Latest Developments_x000D_
12.11 Fuji Capsule_x000D_
12.11.1 Fuji Capsule Company Information_x000D_
12.11.2 Fuji Capsule Non-Animal Softgel Capsules Product Offered_x000D_
12.11.3 Fuji Capsule Non-Animal Softgel Capsules Sales, Revenue, Price and Gross Margin (2019-2021)_x000D_
12.11.4 Fuji Capsule Main Business Overview_x000D_
12.11.5 Fuji Capsule Latest Developments_x000D_
12.12 Sunsho Pharmaceutical_x000D_
12.12.1 Sunsho Pharmaceutical Company Information_x000D_
12.12.2 Sunsho Pharmaceutical Non-Animal Softgel Capsules Product Offered_x000D_
12.12.3 Sunsho Pharmaceutical Non-Animal Softgel Capsules Sales, Revenue, Price and Gross Margin (2019-2021)_x000D_
12.12.4 Sunsho Pharmaceutical Main Business Overview_x000D_
12.12.5 Sunsho Pharmaceutical Latest Developments_x000D_
12.13 Erkang_x000D_
12.13.1 Erkang Company Information_x000D_
12.13.2 Erkang Non-Animal Softgel Capsules Product Offered_x000D_
12.13.3 Erkang Non-Animal Softgel Capsules Sales, Revenue, Price and Gross Margin (2019-2021)_x000D_
12.13.4 Erkang Main Business Overview_x000D_
12.13.5 Erkang Latest Developments_x000D_
_x000D_
13 Research Findings and Conclusion_x000D_
List of Tables_x000D_
Table 1. Non-Animal Softgel Capsules Consumption CAGR by Region (2020-2026) & ($ Millions)_x000D_
Table 2. Major Players of Plant Polysaccharides Softgel Capsules_x000D_
Table 3. Major Players of Starch Softgel Capsules_x000D_
Table 4. Global Non-Animal Softgel Capsules Sales by Type (2016-2021) & (M Capsules)_x000D_
Table 5. Global Non-Animal Softgel Capsules Sales Market Share by Type (2016-2021)_x000D_
Table 6. Global Non-Animal Softgel Capsules Revenue by Type (2016-2021) & ($ million)_x000D_
Table 7. Global Non-Animal Softgel Capsules Revenue Market Share by Type (2016-2021)_x000D_
Table 8. Global Non-Animal Softgel Capsules Sale Price by Type (2016-2021)_x000D_
Table 9. Global Non-Animal Softgel Capsules Sales by Application (2016-2021) & (M Capsules)_x000D_
Table 10. Global Non-Animal Softgel Capsules Sales Market Share by Application (2016-2021)_x000D_
Table 11. Global Non-Animal Softgel Capsules Value by Application (2016-2021)_x000D_
Table 12. Global Non-Animal Softgel Capsules Revenue Market Share by Application (2016-2021)_x000D_
Table 13. Global Non-Animal Softgel Capsules Sale Price by Application (2016-2021)_x000D_
Table 14. Global Non-Animal Softgel Capsules Sales by Company (2019-2021) & (M Capsules)_x000D_
Table 15. Global Non-Animal Softgel Capsules Sales Market Share by Company (2019-2021)_x000D_
Table 16. Global Non-Animal Softgel Capsules Revenue by Company (2019-2021) ($ Millions)_x000D_
Table 17. Global Non-Animal Softgel Capsules Revenue Market Share by Company (2019-2021)_x000D_
Table 18. Global Non-Animal Softgel Capsules Sale Price by Company (2019-2021)_x000D_
Table 19. Key Manufacturers Non-Animal Softgel Capsules Producing Area Distribution and Sales Area_x000D_
Table 20. Players Non-Animal Softgel Capsules Products Offered_x000D_
Table 21. Non-Animal Softgel Capsules Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)_x000D_
Table 22. New Products and Potential Entrants_x000D_
Table 23. Mergers & Acquisitions, Expansion_x000D_
Table 24. Global Non-Animal Softgel Capsules Sales by Region (2016-2021) (M Capsules)_x000D_
Table 25. Global Non-Animal Softgel Capsules Sales Market Share by Region (2016-2021)_x000D_
Table 26. Global Non-Animal Softgel Capsules Revenue by Region (2016-2021) & ($ Millions)_x000D_
Table 27. Global Non-Animal Softgel Capsules Revenue Market Share by Region (2016-2021)_x000D_
Table 28. Americas Non-Animal Softgel Capsules Sales by Country (2016-2021) & (M Capsules)_x000D_
Table 29. Americas Non-Animal Softgel Capsules Sales Market Share by Country (2016-2021)_x000D_
Table 30. Americas Non-Animal Softgel Capsules Revenue by Country (2016-2021) & ($ Millions)_x000D_
Table 31. Americas Non-Animal Softgel Capsules Revenue Market Share by Country (2016-2021)_x000D_
Table 32. Americas Non-Animal Softgel Capsules Sales by Type (2016-2021) & (M Capsules)_x000D_
Table 33. Americas Non-Animal Softgel Capsules Sales Market Share by Type (2016-2021)_x000D_
Table 34. Americas Non-Animal Softgel Capsules Sales by Application (2016-2021) & (M Capsules)_x000D_
Table 35. Americas Non-Animal Softgel Capsules Sales Market Share by Application (2016-2021)_x000D_
Table 36. APAC Non-Animal Softgel Capsules Sales by Region (2016-2021) & (M Capsules)_x000D_
Table 37. APAC Non-Animal Softgel Capsules Sales Market Share by Region (2016-2021)_x000D_
Table 38. APAC Non-Animal Softgel Capsules Revenue by Region (2016-2021) & ($ Millions)_x000D_
Table 39. APAC Non-Animal Softgel Capsules Revenue Market Share by Region (2016-2021)_x000D_
Table 40. APAC Non-Animal Softgel Capsules Sales by Type (2016-2021) & (M Capsules)_x000D_
Table 41. APAC Non-Animal Softgel Capsules Sales Market Share by Type (2016-2021)_x000D_
Table 42. APAC Non-Animal Softgel Capsules Sales by Application (2016-2021) & (M Capsules)_x000D_
Table 43. APAC Non-Animal Softgel Capsules Sales Market Share by Application (2016-2021)_x000D_
Table 44. Europe Non-Animal Softgel Capsules Sales by Country (2016-2021) & (M Capsules)_x000D_
Table 45. Europe Non-Animal Softgel Capsules Sales Market Share by Country (2016-2021)_x000D_
Table 46. Europe Non-Animal Softgel Capsules Revenue by Country (2016-2021) & ($ Millions)_x000D_
Table 47. Europe Non-Animal Softgel Capsules Revenue Market Share by Country (2016-2021)_x000D_
Table 48. Europe Non-Animal Softgel Capsules Sales by Type (2016-2021) & (M Capsules)_x000D_
Table 49. Europe Non-Animal Softgel Capsules Sales Market Share by Type (2016-2021)_x000D_
Table 50. Europe Non-Animal Softgel Capsules Sales by Application (2016-2021) & (M Capsules)_x000D_
Table 51. Europe Non-Animal Softgel Capsules Sales Market Share by Application (2016-2021)_x000D_
Table 52. Middle East & Africa Non-Animal Softgel Capsules Sales by Country (2016-2021) & (M Capsules)_x000D_
Table 53. Middle East & Africa Non-Animal Softgel Capsules Sales Market Share by Country (2016-2021)_x000D_
Table 54. Middle East & Africa Non-Animal Softgel Capsules Revenue by Country (2016-2021) & ($ Millions)_x000D_
Table 55. Middle East & Africa Non-Animal Softgel Capsules Revenue Market Share by Country (2016-2021)_x000D_
Table 56. Middle East & Africa Non-Animal Softgel Capsules Sales by Type (2016-2021) & (M Capsules)_x000D_
Table 57. Middle East & Africa Non-Animal Softgel Capsules Sales Market Share by Type (2016-2021)_x000D_
Table 58. Middle East & Africa Non-Animal Softgel Capsules Sales by Application (2016-2021) & (M Capsules)_x000D_
Table 59. Middle East & Africa Non-Animal Softgel Capsules Sales Market Share by Application (2016-2021)_x000D_
Table 60. Key and Potential Regions of Non-Animal Softgel Capsules_x000D_
Table 61. Key Application and Potential Industries of Non-Animal Softgel Capsules_x000D_
Table 62. Key Challenges of Non-Animal Softgel Capsules_x000D_
Table 63. Key Trends of Non-Animal Softgel Capsules_x000D_
Table 64. Non-Animal Softgel Capsules Distributors List_x000D_
Table 65. Non-Animal Softgel Capsules Customer List_x000D_
Table 66. Global Non-Animal Softgel Capsules Sales Forecast by Region (2021-2026) & (M Capsules)_x000D_
Table 67. Global Non-Animal Softgel Capsules Consumption Market Forecast by Region_x000D_
Table 68. Global Non-Animal Softgel Capsules Revenue Forecast by Region (2021-2026) & ($ millions)_x000D_
Table 69. Global Non-Animal Softgel Capsules Revenue Market Share Forecast by Region (2021-2026)_x000D_
Table 70. Americas Non-Animal Softgel Capsules Sales Forecast by Country (2021-2026) & (M Capsules)_x000D_
Table 71. Americas Non-Animal Softgel Capsules Revenue Forecast by Country (2021-2026) & ($ millions)_x000D_
Table 72. APAC Non-Animal Softgel Capsules Sales Forecast by Region (2021-2026) & (M Capsules)_x000D_
Table 73. APAC Non-Animal Softgel Capsules Revenue Forecast by Region (2021-2026) & ($ millions)_x000D_
Table 74. Europe Non-Animal Softgel Capsules Sales Forecast by Country (2021-2026) & (M Capsules)_x000D_
Table 75. Europe Non-Animal Softgel Capsules Revenue Forecast by Country (2021-2026) & ($ millions)_x000D_
Table 76. Middle East & Africa Non-Animal Softgel Capsules Sales Forecast by Country (2021-2026) & (M Capsules)_x000D_
Table 77. Middle East & Africa Non-Animal Softgel Capsules Revenue Forecast by Country (2021-2026) & ($ millions)_x000D_
Table 78. Global Non-Animal Softgel Capsules Sales Forecast by Type (2021-2026) & (M Capsules)_x000D_
Table 79. Global Non-Animal Softgel Capsules Sales Market Share Forecast by Type (2021-2026)_x000D_
Table 80. Global Non-Animal Softgel Capsules Revenue Forecast by Type (2021-2026) & ($ Millions)_x000D_
Table 81. Global Non-Animal Softgel Capsules Revenue Market Share Forecast by Type (2021-2026)_x000D_
Table 82. Global Non-Animal Softgel Capsules Sales Forecast by Application (2021-2026) & (M Capsules)_x000D_
Table 83. Global Non-Animal Softgel Capsules Sales Market Share Forecast by Application (2021-2026)_x000D_
Table 84. Global Non-Animal Softgel Capsules Revenue Forecast by Application (2021-2026) & ($ Millions)_x000D_
Table 85. Global Non-Animal Softgel Capsules Revenue Market Share Forecast by Application (2021-2026)_x000D_
Table 86. Catalent Basic Information, Non-Animal Softgel Capsules Manufacturing Base, Sales Area and Its Competitors_x000D_
Table 87. Catalent Non-Animal Softgel Capsules Product Offered_x000D_
Table 88. Catalent Non-Animal Softgel Capsules Sales (M Capsules), Revenue ($ Million), Price (US$/Capsule) and Gross Margin (2019-2021E)_x000D_
Table 89. Catalent Main Business_x000D_
Table 90. Catalent Latest Developments_x000D_
Table 91. Procaps Laboratorios Basic Information, Non-Animal Softgel Capsules Manufacturing Base, Sales Area and Its Competitors_x000D_
Table 92. Procaps Laboratorios Non-Animal Softgel Capsules Product Offered_x000D_
Table 93. Procaps Laboratorios Non-Animal Softgel Capsules Sales (M Capsules), Revenue ($ Million), Price (US$/Capsule) and Gross Margin (2019-2021E)_x000D_
Table 94. Procaps Laboratorios Main Business_x000D_
Table 95. Procaps Laboratorios Latest Developments_x000D_
Table 96. EuroCaps Basic Information, Non-Animal Softgel Capsules Manufacturing Base, Sales Area and Its Competitors_x000D_
Table 97. EuroCaps Non-Animal Softgel Capsules Product Offered_x000D_
Table 98. EuroCaps Non-Animal Softgel Capsules Sales (M Capsules), Revenue ($ Million), Price (US$/Capsule) and Gross Margin (2019-2021E)_x000D_
Table 99. EuroCaps Main Business_x000D_
Table 100. EuroCaps Latest Developments_x000D_
Table 101. Best Formulations Basic Information, Non-Animal Softgel Capsules Manufacturing Base, Sales Area and Its Competitors_x000D_
Table 102. Best Formulations Non-Animal Softgel Capsules Product Offered_x000D_
Table 103. Best Formulations Non-Animal Softgel Capsules Sales (M Capsules), Revenue ($ Million), Price (US$/Capsule) and Gross Margin (2019-2021E)_x000D_
Table 104. Best Formulations Main Business_x000D_
Table 105. Best Formulations Latest Developments_x000D_
Table 106. Aenova Basic Information, Non-Animal Softgel Capsules Manufacturing Base, Sales Area and Its Competitors_x000D_
Table 107. Aenova Non-Animal Softgel Capsules Product Offered_x000D_
Table 108. Aenova Non-Animal Softgel Capsules Sales (M Capsules), Revenue ($ Million), Price (US$/Capsule) and Gross Margin (2019-2021E)_x000D_
Table 109. Aenova Main Business_x000D_
Table 110. Aenova Latest Developments_x000D_
Table 111. Captek Basic Information, Non-Animal Softgel Capsules Manufacturing Base, Sales Area and Its Competitors_x000D_
Table 112. Captek Non-Animal Softgel Capsules Product Offered_x000D_
Table 113. Captek Non-Animal Softgel Capsules Sales (M Capsules), Revenue ($ Million), Price (US$/Capsule) and Gross Margin (2019-2021E)_x000D_
Table 114. Captek Main Business_x000D_
Table 115. Captek Latest Developments_x000D_
Table 116. Sirio Basic Information, Non-Animal Softgel Capsules Manufacturing Base, Sales Area and Its Competitors_x000D_
Table 117. Sirio Non-Animal Softgel Capsules Product Offered_x000D_
Table 118. Sirio Non-Animal Softgel Capsules Sales (M Capsules), Revenue ($ Million), Price (US$/Capsule) and Gross Margin (2019-2021E)_x000D_
Table 119. Sirio Main Business_x000D_
Table 120. Sirio Latest Developments_x000D_
Table 121. Bahrain Pharma Basic Information, Non-Animal Softgel Capsules Manufacturing Base, Sales Area and Its Competitors_x000D_
Table 122. Bahrain Pharma Non-Animal Softgel Capsules Product Offered_x000D_
Table 123. Bahrain Pharma Non-Animal Softgel Capsules Sales (M Capsules), Revenue ($ Million), Price (US$/Capsule) and Gross Margin (2019-2021E)_x000D_
Table 124. Bahrain Pharma Main Business_x000D_
Table 125. Bahrain Pharma Latest Developments_x000D_
Table 126. Robinson Pharma Basic Information, Non-Animal Softgel Capsules Manufacturing Base, Sales Area and Its Competitors_x000D_
Table 127. Robinson Pharma Non-Animal Softgel Capsules Product Offered_x000D_
Table 128. Robinson Pharma Non-Animal Softgel Capsules Sales (M Capsules), Revenue ($ Million), Price (US$/Capsule) and Gross Margin (2019-2021E)_x000D_
Table 129. Robinson Pharma Main Business_x000D_
Table 130. Robinson Pharma Latest Developments_x000D_
Table 131. Aland Basic Information, Non-Animal Softgel Capsules Manufacturing Base, Sales Area and Its Competitors_x000D_
Table 132. Aland Non-Animal Softgel Capsules Product Offered_x000D_
Table 133. Aland Non-Animal Softgel Capsules Sales (M Capsules), Revenue ($ Million), Price (US$/Capsule) and Gross Margin (2019-2021E)_x000D_
Table 134. Aland Main Business_x000D_
Table 135. Aland Latest Developments_x000D_
Table 136. Fuji Capsule Basic Information, Non-Animal Softgel Capsules Manufacturing Base, Sales Area and Its Competitors_x000D_
Table 137. Fuji Capsule Non-Animal Softgel Capsules Product Offered_x000D_
Table 138. Fuji Capsule Non-Animal Softgel Capsules Sales (M Capsules), Revenue ($ Million), Price (US$/Capsule) and Gross Margin (2019-2021E)_x000D_
Table 139. Fuji Capsule Main Business_x000D_
Table 140. Fuji Capsule Latest Developments_x000D_
Table 141. Sunsho Pharmaceutical Basic Information, Non-Animal Softgel Capsules Manufacturing Base, Sales Area and Its Competitors_x000D_
Table 142. Sunsho Pharmaceutical Non-Animal Softgel Capsules Product Offered_x000D_
Table 143. Sunsho Pharmaceutical Non-Animal Softgel Capsules Sales (M Capsules), Revenue ($ Million), Price (US$/Capsule) and Gross Margin (2019-2021E)_x000D_
Table 144. Sunsho Pharmaceutical Main Business_x000D_
Table 145. Sunsho Pharmaceutical Latest Developments_x000D_
Table 146. Erkang Basic Information, Non-Animal Softgel Capsules Manufacturing Base, Sales Area and Its Competitors_x000D_
Table 147. Erkang Non-Animal Softgel Capsules Product Offered_x000D_
Table 148. Erkang Non-Animal Softgel Capsules Sales (M Capsules), Revenue ($ Million), Price (US$/Capsule) and Gross Margin (2019-2021E)_x000D_
Table 149. Erkang Main Business_x000D_
Table 150. Erkang Latest Developments_x000D_
List of Figures_x000D_
Figure 1. Picture of Non-Animal Softgel Capsules_x000D_
Figure 2. Non-Animal Softgel Capsules Report Years Considered_x000D_
Figure 3. Research Objectives_x000D_
Figure 4. Research Methodology_x000D_
Figure 5. Research Process and Data Source_x000D_
Figure 6. Global Non-Animal Softgel Capsules Sales Growth Rate 2016-2026 (M Capsules)_x000D_
Figure 7. Global Non-Animal Softgel Capsules Revenue Growth Rate 2016-2026 ($ Millions)_x000D_
Figure 8. Non-Animal Softgel Capsules Sales by Region (2021 & 2026) & ($ millions)_x000D_
Figure 9. Product Picture of Plant Polysaccharides Softgel Capsules_x000D_
Figure 10. Product Picture of Starch Softgel Capsules_x000D_
Figure 11. Global Non-Animal Softgel Capsules Sales Market Share by Type in 2020_x000D_
Figure 12. Global Non-Animal Softgel Capsules Revenue Market Share by Type (2016-2021)_x000D_
Figure 13. Non-Animal Softgel Capsules Consumed in Health Supplements_x000D_
Figure 14. Global Non-Animal Softgel Capsules Market: Health Supplements (2016-2021) & (M Capsules)_x000D_
Figure 15. Non-Animal Softgel Capsules Consumed in Pharmaceutical_x000D_
Figure 16. Global Non-Animal Softgel Capsules Market: Pharmaceutical (2016-2021) & (M Capsules)_x000D_
Figure 17. Non-Animal Softgel Capsules Consumed in Others_x000D_
Figure 18. Global Non-Animal Softgel Capsules Market: Others (2016-2021) & (M Capsules)_x000D_
Figure 19. Global Non-Animal Softgel Capsules Sales Market Share by Application (2016-2021)_x000D_
Figure 20. Global Non-Animal Softgel Capsules Revenue Market Share by Application in 2020_x000D_
Figure 21. Non-Animal Softgel Capsules Revenue Market by Company in 2020 ($ Million)_x000D_
Figure 22. Global Non-Animal Softgel Capsules Revenue Market Share by Company in 2020_x000D_
Figure 23. Global Non-Animal Softgel Capsules Sales Market Share by Regions (2016-2021)_x000D_
Figure 24. Global Non-Animal Softgel Capsules Revenue Market Share by Region in 2020_x000D_
Figure 25. Americas Non-Animal Softgel Capsules Sales 2016-2021 (M Capsules)_x000D_
Figure 26. Americas Non-Animal Softgel Capsules Revenue 2016-2021 ($ Millions)_x000D_
Figure 27. APAC Non-Animal Softgel Capsules Sales 2016-2021 (M Capsules)_x000D_
Figure 28. APAC Non-Animal Softgel Capsules Revenue 2016-2021 ($ Millions)_x000D_
Figure 29. Europe Non-Animal Softgel Capsules Sales 2016-2021 (M Capsules)_x000D_
Figure 30. Europe Non-Animal Softgel Capsules Revenue 2016-2021 ($ Millions)_x000D_
Figure 31. Middle East & Africa Non-Animal Softgel Capsules Sales 2016-2021 (M Capsules)_x000D_
Figure 32. Middle East & Africa Non-Animal Softgel Capsules Revenue 2016-2021 ($ Millions)_x000D_
Figure 33. Americas Non-Animal Softgel Capsules Sales Market Share by Country in 2020_x000D_
Figure 34. Americas Non-Animal Softgel Capsules Revenue Market Share by Country in 2020_x000D_
Figure 35. Americas Non-Animal Softgel Capsules Sales Market Share by Type in 2020_x000D_
Figure 36. Americas Non-Animal Softgel Capsules Sales Market Share by Application in 2020_x000D_
Figure 37. United States Non-Animal Softgel Capsules Revenue Growth 2016-2021 ($ Millions)_x000D_
Figure 38. Canada Non-Animal Softgel Capsules Revenue Growth 2016-2021 ($ Millions)_x000D_
Figure 39. Mexico Non-Animal Softgel Capsules Revenue Growth 2016-2021 ($ Millions)_x000D_
Figure 40. Brazil Non-Animal Softgel Capsules Revenue Growth 2016-2021 ($ Millions)_x000D_
Figure 41. APAC Non-Animal Softgel Capsules Sales Market Share by Region in 2020_x000D_
Figure 42. APAC Non-Animal Softgel Capsules Revenue Market Share by Regions in 2020_x000D_
Figure 43. APAC Non-Animal Softgel Capsules Sales Market Share by Type in 2020_x000D_
Figure 44. APAC Non-Animal Softgel Capsules Sales Market Share by Application in 2020_x000D_
Figure 45. China Non-Animal Softgel Capsules Revenue Growth 2016-2021 ($ Millions)_x000D_
Figure 46. Japan Non-Animal Softgel Capsules Revenue Growth 2016-2021 ($ Millions)_x000D_
Figure 47. Korea Non-Animal Softgel Capsules Revenue Growth 2016-2021 ($ Millions)_x000D_
Figure 48. Southeast Asia Non-Animal Softgel Capsules Revenue Growth 2016-2021 ($ Millions)_x000D_
Figure 49. India Non-Animal Softgel Capsules Revenue Growth 2016-2021 ($ Millions)_x000D_
Figure 50. Australia Non-Animal Softgel Capsules Revenue Growth 2016-2021 ($ Millions)_x000D_
Figure 51. Europe Non-Animal Softgel Capsules Sales Market Share by Country in 2020_x000D_
Figure 52. Europe Non-Animal Softgel Capsules Revenue Market Share by Country in 2020_x000D_
Figure 53. Europe Non-Animal Softgel Capsules Sales Market Share by Type in 2020_x000D_
Figure 54. Europe Non-Animal Softgel Capsules Sales Market Share by Application in 2020_x000D_
Figure 55. Germany Non-Animal Softgel Capsules Revenue Growth 2016-2021 ($ Millions)_x000D_
Figure 56. France Non-Animal Softgel Capsules Revenue Growth 2016-2021 ($ Millions)_x000D_
Figure 57. UK Non-Animal Softgel Capsules Revenue Growth 2016-2021 ($ Millions)_x000D_
Figure 58. Italy Non-Animal Softgel Capsules Revenue Growth 2016-2021 ($ Millions)_x000D_
Figure 59. Russia Non-Animal Softgel Capsules Revenue Growth 2016-2021 ($ Millions)_x000D_
Figure 60. Middle East & Africa Non-Animal Softgel Capsules Sales Market Share by Country in 2020_x000D_
Figure 61. Middle East & Africa Non-Animal Softgel Capsules Revenue Market Share by Country in 2020_x000D_
Figure 62. Middle East & Africa Non-Animal Softgel Capsules Sales Market Share by Type in 2020_x000D_
Figure 63. Middle East & Africa Non-Animal Softgel Capsules Sales Market Share by Application in 2020_x000D_
Figure 64. Egypt Non-Animal Softgel Capsules Revenue Growth 2016-2021 ($ Millions)_x000D_
Figure 65. South Africa Non-Animal Softgel Capsules Revenue Growth 2016-2021 ($ Millions)_x000D_
Figure 66. Israel Non-Animal Softgel Capsules Revenue Growth 2016-2021 ($ Millions)_x000D_
Figure 67. Turkey Non-Animal Softgel Capsules Revenue Growth 2016-2021 ($ Millions)_x000D_
Figure 68. GCC Country Non-Animal Softgel Capsules Revenue Growth 2016-2021 ($ Millions)_x000D_
Figure 69. Channels of Distribution_x000D_
Figure 70. Distributors Profiles_x000D_
